Maravai LifeSciences Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview

Maravai Lifesciences Holdings

04/11/2023 03:06

* Maravai LifeSciences Holdings Inc  MRVI.OQ   MRVI.O  is
expected
to show a fall in quarterly revenue when it reports  results 
    * The San Diego California-based  company is expected to
report  a
60.5% decrease in revenue to $75.523 million from $191.26
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data. The company's guidance on August 7
2023, for the period ended September 30, was for revenue between
$75.00 million and $80.00 million.
    * ​Refinitiv's mean analyst estimate for Maravai
LifeSciences
Holdings Inc is for earnings of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $12​, above​ its last closing price
of $6.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  0.01        0.01       0.00      Missed  -100
 Mar. 31 2023  0.04        0.04       0.03      Missed  -17.2
 Dec. 31 2022  0.35        0.34       0.35      Beat    2.4​
 Sep. 30 2022  0.33        0.33       0.37      Beat    12.2
 ​​Jun.        0.45        0.45       0.54      Beat    18.8
 30 2022                                                
 Mar. 31 2022  0.44        0.44       0.54      Beat    23​
 Dec. 31 2021  0.38        0.38       0.45      Beat    17.1
 Sep. 30 2021  0.36        0.35       0.44      Beat    24.9
 This summary was machine generated November 4 at 03:06 GMT.  All
figures in US dollars  unless otherwise stated